Copyright
©2014 Baishideng Publishing Group Co.
World J Immunol. Mar 27, 2014; 4(1): 34-41
Published online Mar 27, 2014. doi: 10.5411/wji.v4.i1.34
Published online Mar 27, 2014. doi: 10.5411/wji.v4.i1.34
Previously diagnosed or possible high risk of conditions that may be associated with autoimmune thrombocytopenia, for example, HIV, HCV or other infection; other autoimmune/immunodeficiency disorders (including systemic lupus erythematosus; malignancy (e.g., lymphoproliferative disorders); recent vaccination |
Liver disease (including alcoholic liver cirrhosis) |
Drugs (prescription or non-prescription), alcohol abuse, consumption of quinine, tonic water, exposure to environmental toxins |
Bone marrow diseases including myelodysplastic syndromes, leukemias, other malignancies, fibrosis, aplastic anemia and megaloblastic anemia |
Recent transfusions (possibility of post-transfusion purpura) and recent immunizations |
Inherited thrombocytopenia: thrombocytopenia-absent radius syndrome, radioulnar synostosis, congenital amegakaryocytic thrombocytopenia, Wiskott-Aldrich syndrome, MYH9-related disease, Bernard-Soulier syndrome, type II B von Willebrand disease |
Agent | Typical dosing | Time to response | Selected toxicities |
Prednis(ol)one | 0.5-2 mg/kg per day 2-4 wk followed by slow taper | Several days to several weeks | Mood swings, insomnia, anxiety, psychosis, weight gain, cushingoid facies, hyperglycemia, decreased bone density, hypertension, skin changes, gastrointestinal distress and ulceration, avascular necrosis, increased susceptibility to infections, cataracts, adrenal insufficiency |
Methylprednisolone | 30 mg/kg per day 7 d | 2-7 d | |
Dexamethasone | 40 mg/d for 4 d every | Several days to several weeks | |
2-4 wk for 1-4 cycles | |||
IVIg | 0.4 g/kg per day 5 d or 1 g/kg per day 1-2 d | 1-4 d | Headache, aseptic meningitis, renal insufficiency, fever, chills, nausea, thromboembolism, anaphylactoid reactions in patients with IgA-deficiency |
Anti-Rh(D) | 50-75 mcg/kg | 1-5 d | Hemolytic anemia, fever, chills. Rarely, intravascular hemolysis, DIC, and renal failure |
Splenectomy | N/A | 0-24 d | Adverse effects of surgery and anesthesia, increased risk of infection, long-term vascular complications |
Rituximab | 375 mg/m2 weekly 4 wk (lower doses may be effective) | 1-8 wk | Infusion reactions, reactivation of hepatitis B infection, rare cases of progressive multifocal leukoencephalopathy |
Eltrombopag | 12.5-75 mg PO daily | 1-4 wk | Increased bone marrow reticulin, rebound thrombocytopenia, thrombosis, eltrombopag also associated with liver function test abnormalities |
Romiplostim | (1-10 mcg/ kg) SC weekly | 1-4 wk | |
Azathioprine | 1-2 mg/kg per day (maximum 150 mg day) | 1-4 wk | Liver function abnormalities, neutropenia, anemia, infection |
Cyclosporine | 5 mg/kg per day 6 d, then 2.5-3 mg/kg per day (titrated to blood levels of 100-200 ng/mL) | 1-4 wk | Renal failure, hypertension, tremor, infection |
Cyclophosphamide | 1-2 mg/kg PO daily or 0.3-1 g/m2 iv every 2-4 wk 1-3 doses | 1-4 wk | Myelosuppression, infection, secondary malignancy |
Danazol | 200 mg 2-4 times per day | 1-4 wk | Acne, hirsutism, dyslipidemia, amenorrhea, liver function abnormalities |
Dapsone | 75-100 mg daily | 1-4 wk | Hemolytic anemia in patients with G6PD deficiency, rash, methemoglobinemia |
Mycophenolate mofetil | 1000 mg twice daily | 1-4 wk | Headache, back pain, infection |
Vincristine | 1-2 mg iv weekly (total dose 6 mg) | 1-4 wk | Neuropathy, constipation, cytopenias, thrombophlebitis at the infusion site |
- Citation: Kurtoğlu E, Karakuş V. Immune thrombocytopenia in adults. World J Immunol 2014; 4(1): 34-41
- URL: https://www.wjgnet.com/2219-2824/full/v4/i1/34.htm
- DOI: https://dx.doi.org/10.5411/wji.v4.i1.34